Literature DB >> 2986134

Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis.

J K Czop, K F Austen.   

Abstract

Human monocytes possess a receptor for ingestion of particulate activators of the human alternative complement pathway that functions in the absence of plasma proteins and is distinct from the receptors for Fc-IgG and the major cleavage fragment of the third component of complement (C3b). Incubation of monolayers of monocytes with 1.1 X 10(6) to 2.2 X 10(7) glucan particles per ml initiated a phagocytic response comparable to that obtained with zymosan particles, of which beta-glucan is a constituent along with mannan. Maximal quantities of 4.93 +/- 3.43 ng of leukotriene B4 (LTB4) and 0.43 +/- 0.23 ng of leukotriene C4 (LTC4) (mean +/- SD, n = 3) were released by 10(6) monocytes stimulated with 1.1 X 10(7) glucan particles per ml. Preincubation of monocytes with 50 micrograms of soluble beta-glucan per ml reduced subsequent monocyte ingestion of 5 X 10(6) zymosan particles per ml and 2.2 X 10(6) glucan particles per ml by 52% and 55%, respectively, and diminished release of LTB4 by monocytes stimulated with 2 X 10(8) zymosan particles per ml and 8.6 X 10(6) glucan particles per ml by 73% and 61%, respectively. Preincubation with 1 mg of soluble mannan per ml had little effect on monocyte phagocytosis or LTB4 generation in response to either zymosan or glucan particles, and neither soluble beta-glucan nor mannan stimulated generation of LTB4 or LTC4. The effect of pretreatment of monocytes with soluble beta-glucan was time dependent, with the maximal effect being evident within 20 min of pretreatment, and was specific for zymosan or glucan particles in that the LTB4 and LTC4 release induced by 2.5 microM calcium ionophore A23187 was unaffected. That both phagocytosis and leukotriene generation are inhibited by soluble beta-glucan but not by mannan at a rate compatible with the phagocytic process of monocyte monolayers indicates ligand specificity for a beta-glucan receptor. As the beta-glucan receptor recognizes particulate activators of the alternative complement pathway, the nonimmune response to a single stimulus induces complement activation, phagocytosis, and leukotriene generation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986134      PMCID: PMC397643          DOI: 10.1073/pnas.82.9.2751

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

2.  Particle recognition by cultivated macrophages.

Authors:  M Rabinovitch; M J De Stefano
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

3.  Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytes.

Authors:  J K Czop; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

4.  Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.

Authors:  J Hamuro; U Hadding; D Bitter-Suermann
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

5.  A single column packing for the gas-liquid chromatographic separation of various biologically important compounds.

Authors:  K Schmid; L C Chen
Journal:  Prep Biochem       Date:  1976

6.  Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid.

Authors:  P Borgeat; B Samuelsson
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

7.  The glucan components of the cell wall of baker's yeast (Saccharomyces cerevisiae) considered in relation to its ultrastructure.

Authors:  J S Bacon; V C Farmer; D Jones; I F Taylor
Journal:  Biochem J       Date:  1969-09       Impact factor: 3.857

8.  Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytes.

Authors:  J K Czop; D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

9.  Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

10.  The role of membrane receptors for C3b and C3d in phagocytosis.

Authors:  A G Ehlenberger; V Nussenzweig
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.

Authors:  A O Tzianabos
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan.

Authors:  J Soltys; M T Quinn
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 3.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

4.  Candida albicans induces the release of inflammatory mediators from human peripheral blood monocytes.

Authors:  M Castro; J A Bjoraker; M S Rohrbach; A H Limper
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

5.  In vitro studies on the Fc-receptor function of mononuclear phagocytes in rheumatoid arthritis: relation between the Fc-receptor blockade and the concanavalin A-binding capacity of autologous immunoglobulin G.

Authors:  M G Malaise; P Franchimont; C Houssier; J Closset; G Hennen; P R Mahieu
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

Review 6.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components.

Authors:  M Castro; N V Ralston; T I Morgenthaler; M S Rohrbach; A H Limper
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin).

Authors:  B König; W König
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo.

Authors:  A B Onderdonk; R L Cisneros; P Hinkson; G Ostroff
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Candida soluble cell wall beta-glucan facilitates ovalbumin-induced allergic airway inflammation in mice: Possible role of antigen-presenting cells.

Authors:  Ken-ichiro Inoue; Hirohisa Takano; Eiko Koike; Rie Yanagisawa; Toshio Oda; Hiroshi Tamura; Yoshiyuki Adachi; Ken-ichi Ishibashi; Naohito Ohno
Journal:  Respir Res       Date:  2009-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.